Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ALTASCIENCES CLINICAL KANSAS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-09-20 to 2024-09-17
Current total value of award: $3416384
Description: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT.  TASK ORDER NO. 2.  PHASE 1 STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION